Premier Asset Management LLC Neu Base Therapeutics, Inc. Transaction History

Premier Asset Management LLC

  • $0
  • Q1 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 12, 2021
SELL
$6.92 - $12.36 $103,640 - $185,115
-14,977 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$6.92 - $9.25 $13,840 - $18,500
2,000 Added 15.41%
14,977 $105,000
Q3 2020

Nov 16, 2020
BUY
$7.25 - $9.71 $94,083 - $126,006
12,977 New
12,977 $98,000

About NeuBase Therapeutics, Inc.

NBSE Quotes by TradingView
  • Ticker NBSE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,258,700
  • Description
  • NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as ...
More about NBSE
Track This Portfolio

Track Premier Asset Management LLC Portfolio

Follow Premier Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Premier Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Premier Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email